Nonoperating Income (Expense) of Virpax Pharmaceuticals, Inc. from 31 Dec 2022 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Virpax Pharmaceuticals, Inc. quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 31 Dec 2022 to 30 Jun 2024.
  • Virpax Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending 30 Jun 2024 was $8,126, a 94% decline year-over-year.
  • Virpax Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $500,281, a 157% increase from 2022.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Virpax Pharmaceuticals, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $8,126 -$118,594 -94% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $82,033 -$48,498 -37% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q2 2023 $126,720 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $130,531 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1

Virpax Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $500,281 +$305,868 +157% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2024 2023 FY
2022 $194,413 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.